Medical Equipment

Urology Diode Laser System 980nm&1470nm
GIGAALASER, after developing the HPLAS 980nm, combines the two parallel working wavelengths of 980nm and 1470nm to introduce a totally newproduct HPLASIIfor urology.

HPLASII operates dual wavelengths of 980nm and 1470nm running in parallel with the maximum output of 200W, So that it has the advantage that an optimal absorption is achieved in water and hemoglobin, which in turn means a high rate of ablation in combination with a good hemostatic (blood-staunching) effect.

The Dual laser could enable the ejaculation in internal structures of the prostate spared, so it is the very first time for laser method to prevent the so-called retrograde ejaculation, particularly for middle-aged men between 40 and 50 years old who may still have the wish to have children even if they are suffering from BPH.

The excellent hemostatic profile has a positive impact on the healing process: There is virtually no loss of blood during and after procedure, and the internal tissue is spared. The patient experiences relief following the treatment and no longer feels the constant and uncomfortable urge to urinate.

Features

Principle of treatment
The treatment commences by inserting the Cystoscope containing our new BPH probe through the urethra.
The head of the bare fiber is pushed out of the probe.
The dual laser of 980nm and 1470nm is discharged from the probe head.

The operator steers the probe, rotating it to ablate the tissue in a circular motion.
The funnel grows larger step by step and the BPH probe is withdrawn from the prostate at the end.
Urine can once again flow off freely.

Main Advantages
- Safe and minimal-invasive treatment
- Minimal side-effects or complaints following treatment
- In most cases no impact on sexuality and continence
- Additional safety thanks to microsurgical precision
- Treatment possible both on an inpatient and outpatient basis
- Postsurgical catheterization is in many cases necessary only for a short time